White urine in an asymptomatic child.

Autor: Horner KB, Sas DJ

Publikováno v: Journal of Pediatrics; Aug2011, Vol. 159 Issue 2, p351-351, 1p

Primary hyperoxaluria: Long-term outcomes of isolated kidney versus simultaneous liver/kidney transplant.

Autor: Habash NW; Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Jaoudeh RARA; Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA., Hentz RC; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Sas DJ; Division of Pediatric Nephrology, Mayo Clinic, Rochester, Minnesota, USA., Ibrahim SH; Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Hassan S; Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2024 Oct; Vol. 79 (4), pp. 826-834. Date of Electronic Publication: 2024 Jul 15.

Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory.

Autor: Cellini B; Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Baum MA; Department of Nephrology, Boston Children's Hospital, Boston, Massachusetts, USA., Frishberg Y; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel., Groothoff JW; Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam UMC, Amsterdam, the Netherlands., Harris PC; Division of Nephrology and Hypertension and Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA., Hulton SA; Department of Nephrology, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK., Knauf F; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA., Knight J; Department of Urology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Lieske JC; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA., Lowther WT; Center for Structural Biology, Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Moochhala S; UCL Department of Renal Medicine, Royal Free Hospital, London, UK., Nazzal L; Nephrology Division, NYU Langone Health and NYU Grossman School of Medicine, New York, New York, USA., Tasian GE; Division of Pediatric Urology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Whittamore JM; Charles and Jane Pak Center for Mineral Metabolism and Clinical Research UT Southwestern Medical Center, Dallas, Texas, USA., Sas DJ; Division of Pediatric Nephrology and Hypertension, Mayo Clinic Children's Center, Rochester, Minnesota, USA.

Publikováno v: Kidney international reports [Kidney Int Rep] 2024 Sep 01; Vol. 9 (11), pp. 3083-3096. Date of Electronic Publication: 2024 Sep 01 (Print Publication: 2024).

Examination of nutritional factors associated with urolithiasis risk in plant based meat alternatives marketed to children and infants.

Autor: Ungerer GN; Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: Ungerer.garrett@mayo.edu., Liaw CW; Department of Urology, Mayo Clinic, Rochester, MN, USA., Potretzke AM; Department of Urology, Mayo Clinic, Rochester, MN, USA., Sas DJ; Department of Pediatric and Adolescent Medicine, Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA., Gargollo PC; Department of Urology, Mayo Clinic, Rochester, MN, USA., Granberg CF; Department of Urology, Mayo Clinic, Rochester, MN, USA., Koo K; Department of Urology, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Journal of pediatric urology [J Pediatr Urol] 2023 Oct; Vol. 19 (5), pp. 513.e1-513.e7. Date of Electronic Publication: 2023 Apr 17.

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial.

Autor: Hayes W; Department of Paediatric Nephrology, Great Ormond Street Hospital, London, UK. Wesley.Hayes@gosh.nhs.uk., Sas DJ; Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA., Magen D; Pediatric Nephrology Institute, Rambam Health Care Campus, Haifa, Israel., Shasha-Lavsky H; Paediatric Nephrology Unit, Galilee Medical Center, Nahariya, Israel., Michael M; Division of Nephrology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Sellier-Leclerc AL; Hôpital Femme Mère Enfant and Centre d'Investigation Clinique Inserm, Hospices Civils de Lyon, ERKnet, Bron, France., Hogan J; Pediatric Nephrology Department, Hopital Robert-Debré, APHP, Paris, France., Ngo T; Alnylam Pharmaceuticals, Cambridge, MA, USA., Sweetser MT; Alnylam Pharmaceuticals, Cambridge, MA, USA., Gansner JM; Alnylam Pharmaceuticals, Cambridge, MA, USA., McGregor TL; Alnylam Pharmaceuticals, Cambridge, MA, USA., Frishberg Y; Division of Pediatric Nephrology, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Publikováno v: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Apr; Vol. 38 (4), pp. 1075-1086. Date of Electronic Publication: 2022 Aug 01.